NVRH Shares a Public Statement Regarding Supply Challenges for IV Contrast Material

ST. JOHNSBURY, VT (April 14, 2022) – Northeastern Vermont Regional Hospital (NVRH) is committed to providing high quality care for our community. NVRH is committed to maintaining a level of transparency with our patients, including conditions created by factors outside of our control. NVRH is issuing the following public statement to ensure your awareness and understanding of current supply chain impacts.

Due to severe supply chain disruption, all hospitals in the US are experiencing a critical shortage of IV contrast material, called Omnipaque. This agent is used to make blood vessels visible during a CT scan and aid in the diagnosis of pulmonary embolism, dissecting aortic aneurysm, and other potential disruptions of the vascular system such as those that could occur in a motor vehicle crash. NVRH’s ability to perform these tests in all but the most emergent cases will be limited until these supply chain issues get better. This shortage is expected to last until the end of June 2022. During these next several weeks, you may hear your healthcare provider explaining why they are ordering an alternative test which could be more expensive and take longer to schedule.

NVRH will continue to provide high quality care in light of the challenges posed, including exhausting all alternative contrast options and taking other approaches when necessary.